Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

KRTAP2-1 Inhibitors

KRTAP2-1 inhibitors refer to a class of chemical compounds that are designed to interfere with the function of the keratin-associated protein 2-1 (KRTAP2-1), a member of the keratin-associated protein family. KRTAPs are integral in the structure of hair and wool fibers, where they form part of the matrix that surrounds the keratin filaments, contributing to the rigidity and resilience of these fibrous proteins. KRTAP2-1, in particular, is involved in the cross-linking of keratin filaments through disulfide bond formation, a process that stabilizes the overall structure of keratinized tissues. Inhibitors of KRTAP2-1 target this protein to modulate the biochemical properties of keratin filaments, affecting their assembly and interactions within the extracellular matrix of keratinized cells.

The chemical nature of KRTAP2-1 inhibitors is typically characterized by their ability to bind to the active or interaction sites of the KRTAP2-1 protein. These inhibitors may disrupt disulfide bond formation or interfere with other protein-protein interactions within the keratin structure. They could function by directly interacting with the protein or by altering post-translational modifications that regulate KRTAP2-1's activity. Structurally, these inhibitors often possess moieties that can interact with cysteine residues, which are critical for disulfide bond formation. By altering the structural dynamics of KRTAP2-1, these inhibitors provide valuable tools for studying the molecular mechanics of keratinization and protein assembly in fibrous tissues. Understanding how these compounds affect KRTAP2-1 provides insight into the molecular regulation of keratin-associated processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Inhibits protein synthesis, potentially decreasing KRTAP2-1 production.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

Inhibits proteasomal degradation, potentially affecting KRTAP2-1 protein levels.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Binds to DNA and inhibits RNA synthesis, possibly reducing KRTAP2-1 transcription.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$40.00
$210.00
$816.00
$65.00
394
(15)

Causes premature chain termination during protein synthesis, possibly leading to reduced KRTAP2-1 levels.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Inhibits lysosomal function, potentially affecting KRTAP2-1 turnover.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR and can decrease overall protein synthesis, potentially lowering KRTAP2-1 levels.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Proteasome inhibitor, potentially increasing KRTAP2-1 levels due to reduced degradation.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

Inhibits RNA polymerase II, potentially decreasing KRTAP2-1 mRNA synthesis.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Inhibits histone deacetylase, potentially affecting KRTAP2-1 gene expression.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$38.00
$58.00
$102.00
$202.00
8
(1)

Binds to Hsp90 affecting its client proteins' folding and function, including potentially KRTAP2-1.